Reply from authors: the use of blood coagulation products requires a thorough re-evaluation.

Vibede, E; Hvas, C L; Tønnesen, E; Hvas, A-M

Vibede, E; Hvas, C L; Tønnesen, E; Hvas, A-M.

Afiliación

Vibede E; Department of Clinical Biochemistry, Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus N, Denmark.
Hvas CL; Department of Anaesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aarhus N, Denmark.
Tønnesen E; Department of Anaesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aarhus N, Denmark.
Hvas AM; Department of Clinical Biochemistry, Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus N, Denmark.

Acta Anaesthesiol Scand ; 61(7): 855, 2017 08.

Article en En | MEDLINE | ID: mdl-28639352

Asunto(s)

Coagulación Sanguínea; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Coagulación Sanguínea Límite: Humans Idioma: En Revista: Acta Anaesthesiol Scand Año: 2017 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google